The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity.
AGA
GDM
LGA
SGA
gestational
hypertension
neonatal morbidity
Journal
American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476
Informations de publication
Date de publication:
14 Mar 2024
14 Mar 2024
Historique:
received:
15
08
2023
revised:
04
02
2024
accepted:
08
03
2024
medline:
17
3
2024
pubmed:
17
3
2024
entrez:
16
3
2024
Statut:
aheadofprint
Résumé
Gestational diabetes (GDM) is associated with an increased risk of hypertensive disorders of pregnancy (HDP), but there are limited data on fetal growth and neonatal outcomes when both conditions are present. We evaluated the risk of abnormal fetal growth and neonatal morbidity in pregnancies with co-occurrence of GDM and HDP. In a retrospective study of 47,093 singleton pregnancies, we compared the incidence of appropriate for gestational age birthweight (AGA) in pregnancies affected by GDM alone, HDP alone, or both GDM and HDP (GDM/HDP) to that in pregnancies affected by neither disorder using generalized estimating equations (covariates: maternal age, nulliparity, BMI, insurance type, race, marital status and prenatal care site). Secondary outcomes were large for gestational age birthweight (LGA), small for gestational age birthweight (SGA), and a neonatal morbidity composite outcome (stillbirth, hypoglycemia, hyperbilirubinemia, respiratory distress, encephalopathy, preterm delivery, neonatal death, neonatal intensive care unit admission). The median [IQR] birthweight percentile in GDM/HDP (50 [24.0, 78.0], N=179) was similar to unaffected pregnancies (50 [27.0, 73.0], N=35,833). Yet, the absolute rate of AGA was lower for GDM/HDP (78.2% versus 84.9% for unaffected pregnancies). Adjusted analyses showed decreased odds of AGA in GDM/HDP pregnancies compared to unaffected pregnancies (aOR 0.72, 95% confidence interval [0.52, 1.00], P=0.049), and in pregnancies complicated by GDM alone (aOR 0.78 [0.68, 0.89], P<0.001), or HDP alone (aOR 0.73 [0.66, 0.81], P<0.001). The absolute risk of LGA in GDM/HDP pregnancies (14.5%) was greater than in unaffected pregnancies (8.2%) without apparent difference in the risk of SGA (7.3% vs 6.9%). However, in adjusted models comparing GDM/HDP to unaffected pregnancies, neither an association with LGA (aOR 1.33 [0.88, 2.00], P=0.171) nor SGA (aOR 1.32 [0.80, 2.19], P=0.293) reached statistical significance. GDM/HDP carried an increased risk of neonatal morbidity that was greater than that seen in either condition alone (GDM/HDP: aOR 3.13 [2.35, 4.17], P<0.001; GDM alone: aOR 2.01 [1.78, 2.27], P<0.001, HDP alone: aOR 1.38 [1.26, 1.50], P<0.001). While GDM/HDP pregnancies have a similar median birthweight percentile to those affected by neither condition, pregnancies concurrently affected by both conditions have a higher risk of abnormal fetal growth and neonatal morbidity.
Sections du résumé
BACKGROUND
BACKGROUND
Gestational diabetes (GDM) is associated with an increased risk of hypertensive disorders of pregnancy (HDP), but there are limited data on fetal growth and neonatal outcomes when both conditions are present.
OBJECTIVES
OBJECTIVE
We evaluated the risk of abnormal fetal growth and neonatal morbidity in pregnancies with co-occurrence of GDM and HDP.
STUDY DESIGN
METHODS
In a retrospective study of 47,093 singleton pregnancies, we compared the incidence of appropriate for gestational age birthweight (AGA) in pregnancies affected by GDM alone, HDP alone, or both GDM and HDP (GDM/HDP) to that in pregnancies affected by neither disorder using generalized estimating equations (covariates: maternal age, nulliparity, BMI, insurance type, race, marital status and prenatal care site). Secondary outcomes were large for gestational age birthweight (LGA), small for gestational age birthweight (SGA), and a neonatal morbidity composite outcome (stillbirth, hypoglycemia, hyperbilirubinemia, respiratory distress, encephalopathy, preterm delivery, neonatal death, neonatal intensive care unit admission).
RESULTS
RESULTS
The median [IQR] birthweight percentile in GDM/HDP (50 [24.0, 78.0], N=179) was similar to unaffected pregnancies (50 [27.0, 73.0], N=35,833). Yet, the absolute rate of AGA was lower for GDM/HDP (78.2% versus 84.9% for unaffected pregnancies). Adjusted analyses showed decreased odds of AGA in GDM/HDP pregnancies compared to unaffected pregnancies (aOR 0.72, 95% confidence interval [0.52, 1.00], P=0.049), and in pregnancies complicated by GDM alone (aOR 0.78 [0.68, 0.89], P<0.001), or HDP alone (aOR 0.73 [0.66, 0.81], P<0.001). The absolute risk of LGA in GDM/HDP pregnancies (14.5%) was greater than in unaffected pregnancies (8.2%) without apparent difference in the risk of SGA (7.3% vs 6.9%). However, in adjusted models comparing GDM/HDP to unaffected pregnancies, neither an association with LGA (aOR 1.33 [0.88, 2.00], P=0.171) nor SGA (aOR 1.32 [0.80, 2.19], P=0.293) reached statistical significance. GDM/HDP carried an increased risk of neonatal morbidity that was greater than that seen in either condition alone (GDM/HDP: aOR 3.13 [2.35, 4.17], P<0.001; GDM alone: aOR 2.01 [1.78, 2.27], P<0.001, HDP alone: aOR 1.38 [1.26, 1.50], P<0.001).
CONCLUSIONS
CONCLUSIONS
While GDM/HDP pregnancies have a similar median birthweight percentile to those affected by neither condition, pregnancies concurrently affected by both conditions have a higher risk of abnormal fetal growth and neonatal morbidity.
Identifiants
pubmed: 38492713
pii: S0002-9378(24)00438-1
doi: 10.1016/j.ajog.2024.03.009
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.